For: | Wang YF, Feng FL, Zhao XH, Ye ZX, Zeng HP, Li Z, Jiang XQ, Peng ZH. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer. World J Gastroenterol 2014; 20(14): 4085-4092 [PMID: 24744600 DOI: 10.3748/wjg.v20.i14.4085] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i14/4085.htm |
Number | Citing Articles |
1 |
Xiaolei Zhou. Meta-analysis of the diagnostic performance of serum carbohydrate antigen 19-9 for the detection of gallbladder cancer. The International Journal of Biological Markers 2022; 37(1): 81 doi: 10.1177/17246008211068866
|
2 |
Ratna Priya, Vaishali Jain, Javed Akhtar, Geeta Chauhan, Puja Sakhuja, Surbhi Goyal, Anil Kumar Agarwal, Amit Javed, Ankit P. Jain, Ravindra Varma Polisetty, Ravi Sirdeshmukh, Sudeshna Kar, Poonam Gautam. Plasma-derived candidate biomarkers for detection of gallbladder carcinoma. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02923-7
|
3 |
I. Sulieman, S. Mohamed, W. Elmoghazy, A. Alaboudy, H. Khalaf, A. Elaffandi. The value of diffusion-weighted imaging in diagnosing gallbladder malignancy: performance of a new parameter. Clinical Radiology 2021; 76(9): 709.e7 doi: 10.1016/j.crad.2021.05.010
|
4 |
Alexander Ney, Daniel C. Osei‐Bordom, Andres Garcia‐Sampedro, Pilar Acedo, Giuseppe K. Fusai, Martyn Stott, Phillip Hopley, Chandni Patel, Lucy Oldfield, William Greenhalf, Eithne Costello, Stephen P. Pereira. Gastrointestinal Oncology ‐ A Critical Multidisciplinary Team Approach 2e. 2024; : 291 doi: 10.1002/9781119756422.ch17
|
5 |
Patricia García, Angela Lamarca, Javier Díaz, Enrique Carrera, Juan Roa. Current and New Biomarkers for Early Detection, Prognostic Stratification, and Management of Gallbladder Cancer Patients. Cancers 2020; 12(12): 3670 doi: 10.3390/cancers12123670
|
6 |
Hai Luo, Kexin Shen, Hongyan Sun, Ruiqi Li, Zeming Wang, Zhongshi Xie. Clinical significance of serum neuron-specific enolase in gastric adenocarcinoma. Medicine 2020; 99(16): e19829 doi: 10.1097/MD.0000000000019829
|
7 |
Qing Pang, Ling-Qiang Zhang, Rui-Tao Wang, Jian-Bin Bi, Jing-Yao Zhang, Kai Qu, Su-Shun Liu, Si-Dong Song, Xin-Sen Xu, Zhi-Xin Wang, Chang Liu. Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma. World Journal of Gastroenterology 2015; 21(21): 6675-6683 doi: 10.3748/wjg.v21.i21.6675
|
8 |
Zefan Liu, Guannan Zhu, Xian Jiang, Yunuo Zhao, Hao Zeng, Jing Jing, Xuelei Ma. Survival Prediction in Gallbladder Cancer Using CT Based Machine Learning. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.604288
|
9 |
Vikram Chaudhari, Manish Bhandare, Shailesh V. Shrikhande. Surgical Diseases of the Pancreas and Biliary Tree. 2018; : 391 doi: 10.1007/978-981-10-8755-4_15
|
10 |
Li Guo, Mengting Liu, Yuyang Dou, Rui Duan, Lulu Shen, Lin Jia, Jun Wang, Changxian Li, Xiangcheng Li, Tingming Liang. Screening and identification of haptoglobin showing its important role in pathophysiological process of gallbladder carcinoma. Gene 2021; 776: 145429 doi: 10.1016/j.gene.2021.145429
|
11 |
Wentao Miao, Feng Liu, Yarong Guo, Rui Zhang, Yan Wang, Jun Xu. Research progress on prognostic factors of gallbladder carcinoma. Journal of Cancer Research and Clinical Oncology 2024; 150(10) doi: 10.1007/s00432-024-05975-0
|
12 |
Rashpal Singh, Puneet Mahajan, Rizul Prasher, Vivek Rajdev, Jagwinder Singh, Cliffin Mathai Kattoor, Kavita Mardi, Jagdish Gupta. Immunoglobulin (IgG4) Sclerosing Cholecystitis-Camouflaging Gall Bladder Cancer—a Case Report and Review of Literature. SN Comprehensive Clinical Medicine 2023; 5(1) doi: 10.1007/s42399-022-01371-2
|
13 |
Jiahao Hu, Jiasheng Cao, Ren’an Jin, Bin Zhang, Win Topatana, Sarun Juengpanich, Shijie Li, Tian’en Chen, Ziyi Lu, Xiujun Cai, Mingyu Chen. Inhibition of AMPK/PFKFB3 mediated glycolysis synergizes with penfluridol to suppress gallbladder cancer growth. Cell Communication and Signaling 2022; 20(1) doi: 10.1186/s12964-022-00882-8
|
14 |
Iago Justo, Alberto Marcacuzco, Oana-Anisa Nutu, Alejandro Manrique, Jorge Calvo, Óscar Caso, Félix Cambra, Álvaro García-Sesma, Luis Carlos Jiménez-Romero. A retrospective analysis of patients with gallbladder cancer: surgical treatment and survival according to tumor stage. Revista Española de Enfermedades Digestivas 2018; 110 doi: 10.17235/reed.2018.5435/2017
|
15 |
Cristian Carrasco, Andrés Tittarelli, Natalia Paillaleve, Maeva Del Pozo, Daniel Rojas-Sepúlveda, Omar Barría, Paula Fluxá, Melissa Hott, Carolina Martin, Claudia Quezada, Flavio Salazar-Onfray. The Evaluation of 17 Gastrointestinal Tumor Markers Reveals Prognosis Value for MUC6, CK17, and CD10 in Gallbladder-Cancer Patients. Diagnostics 2021; 11(2): 153 doi: 10.3390/diagnostics11020153
|
16 |
Zhijian Wen, Anfeng Si, Jue Yang, Pinghua Yang, Xinwei Yang, Hu Liu, Xingzhou Yan, Wengang Li, Baohua Zhang. Elevation of CA19-9 and CEA is associated with a poor prognosis in patients with resectable gallbladder carcinoma. HPB 2017; 19(11): 951 doi: 10.1016/j.hpb.2017.06.011
|
17 |
Pritam Prakash, Sanjay Kumar, Rekha kumari, Shraddha Raj, Sweta kumari. DIAGNOSTIC SIGNIFICANCE OF SERUM CA242, CA19.9 AND CEA IN DIAGNOSIS OF GALL BLADDER CANCER. INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH 2021; : 74 doi: 10.36106/ijsr/1602781
|
18 |
Manoj K. Bind, Ravi R. Mishra, Varsha Kumar, Vatsala Misra, Premala A. Singh. Serum CA 19-9 and CA 125 as a diagnostic marker in carcinoma of gallbladder. Indian Journal of Pathology and Microbiology 2021; 64(1): 65 doi: 10.4103/IJPM.IJPM_494_19
|
19 |
Dhakshinamoorthy Ganeshan, Avinash Kambadakone, Paul Nikolaidis, Vivek Subbiah, Ishwaria M. Subbiah, Catherine Devine. Current update on gallbladder carcinoma. Abdominal Radiology 2021; 46(6): 2474 doi: 10.1007/s00261-020-02871-2
|
20 |
Rui Zhang, Hao-Ming Lin, Zhao-Xi Cai, Su-Juan Du, Hong Zeng, Lei-Bo Xu, Jie Wang, Chao Liu. Clinical strategies for differentiating IgG4-related cholecystitis from gallbladder carcinoma to avoid unnecessary surgical resection. Science China Life Sciences 2020; 63(5): 764 doi: 10.1007/s11427-019-9539-6
|
21 |
Junyi He, Sheng Shen, Weiqi Lu, Yuhong Zhou, Yingyong Hou, Yong Zhang, Ying Jiang, Houbao Liu, Yebo Shao. HDAC1 promoted migration and invasion binding with TCF12 by promoting EMT progress in gallbladder cancer. Oncotarget 2016; 7(22): 32754 doi: 10.18632/oncotarget.8740
|
22 |
Wei Feng, Ye Ding, Wei Zong, Shaoqing Ju. Non-coding RNAs in regulating gastric cancer metastasis. Clinica Chimica Acta 2019; 496: 125 doi: 10.1016/j.cca.2019.07.003
|
23 |
Natalia Calanzani, Paige E. Druce, Claudia Snudden, Kristi M. Milley, Rachel Boscott, Dawnya Behiyat, Smiji Saji, Javiera Martinez-Gutierrez, Jasmeen Oberoi, Garth Funston, Mike Messenger, Jon Emery, Fiona M. Walter. Identifying Novel Biomarkers Ready for Evaluation in Low-Prevalence Populations for the Early Detection of Upper Gastrointestinal Cancers: A Systematic Review. Advances in Therapy 2021; 38(2): 793 doi: 10.1007/s12325-020-01571-z
|
24 |
Tommaso Schepis, Ivo Boškoski, Andrea Tringali, Vincenzo Bove, Guido Costamagna. Palliation in Gallbladder Cancer: The Role of Gastrointestinal Endoscopy. Cancers 2022; 14(7): 1686 doi: 10.3390/cancers14071686
|
25 |
Wen-Shu Ma, Jing-Guang Ma, Li-Na Xing. Efficacy and safety of recombinant human adenovirus p53 combined with chemoradiotherapy in the treatment of recurrent nasopharyngeal carcinoma. Anti-Cancer Drugs 2017; 28(2): 230 doi: 10.1097/CAD.0000000000000448
|
26 |
Anand Bharathan, V. Sitaram. GI Surgery Annual. GI Surgery Annual 2019; 25: 139 doi: 10.1007/978-981-13-3227-2_5
|
27 |
杰超 彭. Index Screening and Model Construction for Predicting Benign and Malignant Gallbladder Polyps with Maximum Diameter ≤2 cm. Advances in Clinical Medicine 2023; 13(04): 6757 doi: 10.12677/ACM.2023.134945
|
28 |
Elżbieta Pawluczuk, Marta Łukaszewicz-Zając, Barbara Mroczko. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer. International Journal of Molecular Sciences 2023; 24(10): 8833 doi: 10.3390/ijms24108833
|
29 |
Norah E. Liang, Martin S. Taylor, Cristina R. Ferrone. A Rare Case of Gallbladder Small Cell Carcinoma. Journal of Gastrointestinal Surgery 2021; 25(2): 561 doi: 10.1007/s11605-020-04620-8
|
30 |
Mingyu Chen, Jiasheng Cao, Yang Bai, Chenhao Tong, Jian Lin, Vishal Jindal, Leandro Cardoso Barchi, Silvio Nadalin, Sherry X. Yang, Antonio Pesce, Fabrizio Panaro, Arie Ariche, Keita Kai, Riccardo Memeo, Tanios Bekaii-Saab, Xiujun Cai. Development and Validation of a Nomogram for Early Detection of Malignant Gallbladder Lesions. Clinical and Translational Gastroenterology 2019; 10(10): e00098 doi: 10.14309/ctg.0000000000000098
|
31 |
Sajid Muhammad Tanveer, Hussain Syed Mukarram, Hashmi Shoaib Nayyar, Mustafa Qurat Ul Ain, Shaheen Neelofar. Incidental gallbladder cancer: Missing links in Pakistani population. International Journal of Hepatobiliary and Pancreatic Diseases 2017; 7(1): 1 doi: 10.5348/ijhpd-2017-65-OA-1
|
32 |
Jingrui Dou, Wubulitalifu Dawuti, Jintian Li, Hui Zhao, Run Zhou, Jing Zhou, Renyong Lin, Guodong Lü. Rapid detection of serological biomarkers in gallbladder carcinoma using fourier transform infrared spectroscopy combined with machine learning. Talanta 2023; 259: 124457 doi: 10.1016/j.talanta.2023.124457
|
33 |
Lin-Li Cao, Hua Shan. Large and unusual presentation of gallbladder adenoma: A case report. World Journal of Clinical Cases 2020; 8(21): 5415-5419 doi: 10.12998/wjcc.v8.i21.5415
|
34 |
Fei Xiang, Xiaoyuan Liang, Lili Yang, Xingyu Liu, Sheng Yan. Contrast-enhanced CT radiomics for prediction of recurrence-free survival in gallbladder carcinoma after surgical resection. European Radiology 2022; 32(10): 7087 doi: 10.1007/s00330-022-08858-5
|
35 |
Jian-Min Qin. Causes of misdiagnosis and missed diagnosis and therapeutic and preventive strategies for unexpected gallbladder carcinoma. World Chinese Journal of Digestology 2020; 28(23): 1167 doi: 10.11569/wcjd.v28.i23.1167
|
36 |
Ji-Qiao Zhu, Dong-Dong Han, Xian-Liang Li, Jian-Tao Kou, Hua Fan, Qiang He. Predictors of incidental gallbladder cancer in elderly patients. Hepatobiliary & Pancreatic Diseases International 2015; 14(1): 96 doi: 10.1016/S1499-3872(14)60292-7
|
37 |
Zhanghui Li, Yelei Liu, Junhui Fu, Joseph Mugaanyi, Junrong Yan, Caide Lu, Jing Huang. Bile is a reliable and valuable source to study cfDNA in biliary tract cancers. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.961939
|
38 |
Jianchun Xiao, Ruilin Zhou, Boyao Zhang, Binglu Li. Noninvasive preoperative differential diagnosis of gallbladder carcinoma and xanthogranulomatous cholecystitis: A retrospective cohort study of 240 patients. Cancer Medicine 2022; 11(1): 176 doi: 10.1002/cam4.4442
|
39 |
Raised CA19–9 and CEA have prognostic relevance in gallbladder carcinoma. BMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07334-x
|
40 |
Min su You, Ji Kon Ryu, Young Hoon Choi, Jin Ho Choi, Gunn Huh, Woo Hyun Paik, Sang Hyub Lee, Yong-Tae Kim. Therapeutic outcomes and prognostic factors in unresectable gallbladder cancer treated with gemcitabine plus cisplatin. BMC Cancer 2019; 19(1) doi: 10.1186/s12885-018-5211-y
|
41 |
Rohan Shotton, Angela Lamarca, Juan Valle, Mairéad G McNamara. Potential utility of liquid biopsies in the management of patients with biliary tract cancers: A review. World Journal of Gastrointestinal Oncology 2021; 13(9): 1073-1085 doi: 10.4251/wjgo.v13.i9.1073
|
42 |
WEIQING LUO, ZHIGANG REN, SHENG GAO, HAILONG JIN, GEER ZHANG, LIN ZHOU, SHUSEN ZHENG. Clinical correlation of calpain-1 and glypican-3 expression with gallbladder carcinoma. Oncology Letters 2016; 11(2): 1345 doi: 10.3892/ol.2016.4079
|
43 |
Tong Yifan, Li Zheyong, Chen Miaoqin, Shi Liang, Cai Xiujun. A predictive model for survival of gallbladder adenocarcinoma. Surgical Oncology 2018; 27(3): 365 doi: 10.1016/j.suronc.2018.05.007
|
44 |
Pinghua Yang, Fengliang Song, Xinwei Yang, Xingzhou Yan, Xinyu Huang, Zhengjun Qiu, Zhijian Wen, Chi Liang, Xianglei Xin, Zhengqin Lei, Kecheng Zhang, Jue Yang, Hu Liu, Hongcheng Wang, Shijun Xiang, Liang Li, Baohua Zhang, Hongyang Wang. Exosomal MicroRNA signature acts as an efficient biomarker for non-invasive diagnosis of gallbladder carcinoma. iScience 2022; 25(9): 104816 doi: 10.1016/j.isci.2022.104816
|
45 |
Fei Liu, Jun‐Ke Wang, Wen‐Jie Ma, Qin Yang, Hai‐Jie Hu, Fu‐Yu Li. Clinical value of preoperative CA19‐9 levels in evaluating resectability of gallbladder carcinoma. ANZ Journal of Surgery 2019; 89(3) doi: 10.1111/ans.14893
|
46 |
Hiroaki Fujita, Taiichi Wakiya, Keinosuke Ishido, Norihisa Kimura, Hayato Nagase, Taishu Kanda, Masashi Matsuzaka, Yoshihiro Sasaki, Kenichi Hakamada. Differential diagnoses of gallbladder tumors using CT‐based deep learning. Annals of Gastroenterological Surgery 2022; 6(6): 823 doi: 10.1002/ags3.12589
|
47 |
Lingqiang Zhang, Runchen Miao, Xiude Zhang, Wei Chen, Yanyan Zhou, Ruitao Wang, Ruiyao Zhang, Qing Pang, Xinsen Xu, Chang Liu. Exploring the diagnosis markers for gallbladder cancer based on clinical data. Frontiers of Medicine 2015; 9(3): 350 doi: 10.1007/s11684-015-0402-2
|
48 |
Xiaoyang Li, Sifeng Li, Zhenqi Zhang, Dandan Huang. Association of multiple tumor markers with newly diagnosed gastric cancer patients: a retrospective study. PeerJ 2022; 10: e13488 doi: 10.7717/peerj.13488
|
49 |
Pengfei Li, Lujun Song. Prognostic Evaluation for Patients over 45 Years Old with Gallbladder Adenocarcinoma Resection: A SEER-Based Nomogram Analysis. BioMed Research International 2020; 2020: 1 doi: 10.1155/2020/6370946
|
50 |
Seema Rani Sinha, Prem Prakash, Rakesh Kumar Singh, Dinesh Kumar Sinha. Assessment of tumor markers CA 19-9, CEA, CA 125, and CA 242 for the early diagnosis and prognosis prediction of gallbladder cancer. World Journal of Gastrointestinal Surgery 2022; 14(11): 1272-1284 doi: 10.4240/wjgs.v14.i11.1272
|
51 |
Margaret G Keane, Amar Shah, Stephen P Pereira, Deepak Joshi. Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancy. F1000Research 2017; 6: 1643 doi: 10.12688/f1000research.11371.1
|
52 |
Xiaorong Chen, Yuwen Zhou, Xinyao Shu, Guixia Wei, Meng Qiu. Gallbladder carcinosarcoma: current perspectives and new development. Expert Review of Gastroenterology & Hepatology 2021; 15(10): 1107 doi: 10.1080/17474124.2021.1919509
|
53 |
Leijuan Gan, Shaohua Ren, Mengran Lang, Guangtao Li, Feng Fang, Lu Chen, Yayue Liu, Ruyu Han, Kangwei Zhu, Tianqiang Song. Predictive Value of Preoperative Serum AFP, CEA, and CA19-9 Levels in Patients with Single Small Hepatocellular Carcinoma: Retrospective Study. Journal of Hepatocellular Carcinoma 2022; : 799 doi: 10.2147/JHC.S376607
|
54 |
Rishit Mani, Amit Gupta, Sweety Gupta, Bela Goyal, Rahul Mishra, Amoli Tandon, Oshin Sharma, Kusum K Rohilla, Sanjeev Kishore, Puneet Dhar. Expression of ER, PR, and HER-2 Neu and correlation with tumor markers in gall bladder carcinoma. Journal of Cancer Research and Therapeutics 2023; 19(5): 1279 doi: 10.4103/jcrt.jcrt_1754_21
|
55 |
Li-Fan Wang, Qiao Wang, Feng Mao, Shi-Hao Xu, Li-Ping Sun, Ting-Fan Wu, Bo-Yang Zhou, Hao-Hao Yin, Hui Shi, Ya-Qin Zhang, Xiao-Long Li, Yi-Kang Sun, Dan Lu, Cong-Yu Tang, Hai-Xia Yuan, Chong-Ke Zhao, Hui-Xiong Xu. Risk stratification of gallbladder masses by machine learning-based ultrasound radiomics models: a prospective and multi-institutional study. European Radiology 2023; 33(12): 8899 doi: 10.1007/s00330-023-09891-8
|
56 |
Tian-Run Lv, Jun-Ke Wang, Fu-Yu Li, Hai-Jie Hu. Prognostic factors for resected cases with gallbladder carcinoma: A systematic review and meta-analysis. International Journal of Surgery 2024; doi: 10.1097/JS9.0000000000001403
|
57 |
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancy. Current Problems in Surgery 2021; 58(2): 100854 doi: 10.1016/j.cpsurg.2020.100854
|
58 |
Yingjie He, Xuezhi Du, Fan Yuan, Caigu Yan, Ming Chen, Lei Han, Jinjin Sun. Long non‑coding RNAs in gallbladder cancer: From mechanisms to therapeutic opportunities (Review). International Journal of Oncology 2023; 64(2) doi: 10.3892/ijo.2023.5604
|
59 |
Asmita Chopra, Alessandro Paniccia. Biliary Tract - Review and Recent Progress. 2023; doi: 10.5772/intechopen.109208
|
60 |
Ernesto Lopez, Sofía Hidalgo, Eduardo Roa, Javiera Gómez, Carlos Hermansen Truan, Evy Sanders, Cristian Carrasco, Rodrigo Pacheco, Flavio Salazar-Onfray, Manuel Varas-Godoy, Vincenzo Borgna, Alvaro Lladser. Preclinical evaluation of chimeric antigen receptor T cells targeting the carcinoembryonic antigen as a potential immunotherapy for gallbladder cancer. OncoImmunology 2023; 12(1) doi: 10.1080/2162402X.2023.2225291
|
61 |
Maria Diab, Philip A. Philip. Textbook of Gastrointestinal Oncology. 2019; : 197 doi: 10.1007/978-3-030-18890-0_12
|
62 |
Eduardo E. Montalvo-Jave, Amir A. Rahnemai- Azar, Dimitrios Papaconstantinou, Mariana Espejel Deloiza, Diamantis I. Tsilimigras, Dimitrios Moris, German Eduardo Mendoza-Barrera, Sharon M. Weber, Timothy M. Pawlik. Molecular pathways and potential biomarkers in gallbladder cancer: A comprehensive review. Surgical Oncology 2019; 31: 83 doi: 10.1016/j.suronc.2019.09.006
|
63 |
Akshay S Bedmutha, Archi Agrawal, Venkatesh Rangarajan, Mahesh Goel, Shraddha Patkar, Ameya D. Puranik, Mukta Ramadwar, Nilendu C. Purandare, Sneha Shah, Sayak Choudhury. Diagnostic performance of F-18 FDG PET/CT in recurrent adenocarcinoma gallbladder and its impact on post-recurrence survival. Japanese Journal of Radiology 2023; 41(2): 201 doi: 10.1007/s11604-022-01340-8
|
64 |
Temitope Ajibawo, Oluwatimilehin Okunowo. Prevalence and Factors Associated With Palliative Care Utilization Among Hospitalized Patients With Gallbladder Cancer- A National Inpatient Sample Analysis. American Journal of Hospice and Palliative Medicine® 2024; doi: 10.1177/10499091241262968
|
65 |
K. R. Hossain, J. D. Escobar Bermeo, K. Warton, S. M. Valenzuela. New Approaches and Biomarker Candidates for the Early Detection of Ovarian Cancer. Frontiers in Bioengineering and Biotechnology 2022; 10 doi: 10.3389/fbioe.2022.819183
|
66 |
Tianwei Fu, Yating Bao, Zhihan Zhong, Zhenyu Gao, Taiwei Ye, Chengwu Zhang, Huang Jing, Zunqiang Xiao. Machine learning-based diagnostic model for preoperative differentiation between xanthogranulomatous cholecystitis and gallbladder carcinoma: a multicenter retrospective cohort study. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1355927
|
67 |
Shiya Zheng, Zixue Yang, Yanping Chen, Dan Wu, Shoubing Zhou, Lulu Li, Xiaoxiao Jin, Xiu Zhang, Zhen Liu, Cailian Wang. Simultaneous and combined detection of multiple tumor markers for cancer screening in human serum by an upgraded photonic crystal-encoded suspension array. RSC Advances 2016; 6(95): 92267 doi: 10.1039/C6RA18973C
|
68 |
Eijiro Ueta, Koichiro Tsutsumi, Hironari Kato, Hiroshi Matsushita, Hidenori Shiraha, Masakuni Fujii, Kazuyuki Matsumoto, Shigeru Horiguchi, Hiroyuki Okada. Extracellular vesicle-shuttled miRNAs as a diagnostic and prognostic biomarker and their potential roles in gallbladder cancer patients. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-91804-0
|
69 |
Yuqing Sun, Yongling Tang, Long Yu, Yuhao Wang, Shuang Peng, Xiang Zhou. Circulating nucleic acids as liquid biopsies for disease prediction, screening and diagnosis. Science China Chemistry 2023; 66(11): 3006 doi: 10.1007/s11426-023-1727-9
|
70 |
Myongjin Kim, Hongbeom Kim, Youngmin Han, Heeju Sohn, Jae Seung Kang, Wooil Kwon, Jin-Young Jang. Prognostic Value of Carcinoembryonic Antigen (CEA) and Carbohydrate Antigen 19-9 (CA 19-9) in Gallbladder Cancer; 65 IU/mL of CA 19-9 Is the New Cut-Off Value for Prognosis. Cancers 2021; 13(5): 1089 doi: 10.3390/cancers13051089
|
71 |
Sridhar Mishra, Pallavi Srivastava, Anshuman Pandey, Akash Agarwal, Saumya Shukla, Nuzhat Husain. Panel of serum long non-coding RNAs as potential non-invasive biomarkers for gallbladder carcinoma. Non-coding RNA Research 2024; 9(2): 583 doi: 10.1016/j.ncrna.2024.02.005
|
72 |
Zhu Jing, Li Huidan. Serum expression of tumor marker CA242 in patients with different gynecological diseases. Laboratory Medicine 2023; doi: 10.1093/labmed/lmad017
|
73 |
Xin Guo, Xiaohui Lv, Cheng Fang, Xing Lv, Fengsong Wang, Dongmei Wang, Jun Zhao, Yueyun Ma, Yu Xue, Quan Bai, Xuebiao Yao, Yong Chen. Dysbindin as a novel biomarker for pancreatic ductal adenocarcinoma identified by proteomic profiling. International Journal of Cancer 2016; 139(8): 1821 doi: 10.1002/ijc.30227
|
74 |
Tsinrong Lee, Thomas Zheng Jie Teng, Vishal G Shelat. Carbohydrate antigen 19-9 — tumor marker: Past, present, and future. World Journal of Gastrointestinal Surgery 2020; 12(12): 468-490 doi: 10.4240/wjgs.v12.i12.468
|
75 |
Rajani Rai, Saumyak Gosai, Chinthalapally V. Rao, Vishal Chandra. Molecular Diagnostics in Cancer Patients. 2019; : 11 doi: 10.1007/978-981-13-5877-7_2
|
76 |
Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu. A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer. Cancer Research and Treatment 2024; 56(2): 602 doi: 10.4143/crt.2023.726
|
77 |
Hong-Xin Peng, Lin Yang, Bang-Shun He, Yu-Qin Pan, Hou-Qun Ying, Hui-Ling Sun, Kang Lin, Xiu-Xiu Hu, Tao Xu, Shu-Kui Wang. Combination of preoperative NLR, PLR and CEA could increase the diagnostic efficacy for I-III stage CRC. Journal of Clinical Laboratory Analysis 2017; 31(5): e22075 doi: 10.1002/jcla.22075
|
78 |
Masato Nagino, Satoshi Hirano, Hideyuki Yoshitomi, Taku Aoki, Katsuhiko Uesaka, Michiaki Unno, Tomoki Ebata, Masaru Konishi, Keiji Sano, Kazuaki Shimada, Hiroaki Shimizu, Ryota Higuchi, Toshifumi Wakai, Hiroyuki Isayama, Takuji Okusaka, Toshio Tsuyuguchi, Yoshiki Hirooka, Junji Furuse, Hiroyuki Maguchi, Kojiro Suzuki, Hideya Yamazaki, Hiroshi Kijima, Akio Yanagisawa, Masahiro Yoshida, Yukihiro Yokoyama, Takashi Mizuno, Itaru Endo. Clinical practice guidelines for the management of biliary tract cancers 2019: The 3rd English edition. Journal of Hepato-Biliary-Pancreatic Sciences 2021; 28(1): 26 doi: 10.1002/jhbp.870
|
79 |
Xi-Fen Liu, Lin-Ying Zhou, Zi-Hao Wei, Jia-Xin Liu, Ang Li, Xiao-Zhong Wang, Hou-Qun Ying. The Diagnostic Role of Circulating Inflammation-Based Biomarker in Gallbladder Carcinoma. Biomarkers in Medicine 2018; 12(10): 1095 doi: 10.2217/bmm-2018-0049
|
80 |
Xin Zhang, Xinru Gui, Yanli Zhang, Qi Liu, Liqiang Zhao, Jingxian Gao, Jian Ji, Yi Zhang. A Panel of Bile Volatile Organic Compounds Servers as a Potential Diagnostic Biomarker for Gallbladder Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.858639
|
81 |
Hasan Çağrı Yıldırım, Gozde Kavgaci, Elvin Chalabiyev, Omer Dizdar. Advances in the Early Detection of Hepatobiliary Cancers. Cancers 2023; 15(15): 3880 doi: 10.3390/cancers15153880
|
82 |
Qigu Yao, Wenyi Chen, Feiqiong Gao, Yuchen Wu, Lingling Zhou, Haoying Xu, Jong Yu, Xinli Zhu, Lan Wang, Lanjuan Li, Hongcui Cao. Characteristic Analysis of Featured Genes Associated with Cholangiocarcinoma Progression. Biomedicines 2023; 11(3): 847 doi: 10.3390/biomedicines11030847
|
83 |
Surgical Management of Gallbladder Carcinoma. Indian Journal of Surgery 2021; 83(S3): 625 doi: 10.1007/s12262-019-02050-8
|
84 |
Junya Mita, Kazuhiro Tada, Yusuke Kuboyama, Kentaro Iwaki, Shun Nakamura, Kengo Fukuzawa. Poorly differentiated adenocarcinoma with signet ring cells of the gallbladder producing a high level of alpha-fetoprotein: A case report. International Journal of Surgery Case Reports 2022; 101: 107780 doi: 10.1016/j.ijscr.2022.107780
|
85 |
Yang Zhang, Xuyang Yang, Zixuan Zhuang, Mingtian Wei, Wenjian Meng, Xiangbing Deng, Ziqiang Wang. The diagnostic value of exosomal circular RNAs in cancer patients: A systematic review and meta‐analysis. Cancer Medicine 2023; 12(2): 1709 doi: 10.1002/cam4.5012
|
86 |
Kaige Deng, Jiali Xing, Gang Xu, Ruixue Ma, Bao Jin, Zijian Leng, Xueshuai Wan, Jingyong Xu, Xiaolei Shi, Jiangchun Qiao, Jiayin Yang, Jinghai Song, Yongchang Zheng, Xinting Sang, Shunda Du. Novel multifactor predictive model for postoperative survival in gallbladder cancer: a multi-center study. World Journal of Surgical Oncology 2024; 22(1) doi: 10.1186/s12957-024-03533-z
|
87 |
Jae Woo Lee, Yong-Tae Kim, Sang Hyub Lee, Jun Hyuk Son, Jin Woo Kang, Ji Kon Ryu, Dong Kee Jang, Woo Hyun Paik, Ban Seok Lee. Tumor Marker Kinetics as Prognosticators in Patients with Unresectable Gallbladder Adenocarcinoma Undergoing Palliative Chemotherapy. Gut and Liver 2018; 12(1): 102 doi: 10.5009/gnl16588
|
88 |
Can Li, Xiaohui Luan, Xiao Bi, Shengxin Chen, Yue Pan, Jingfeng Zhang, Yun Han, Xiaodan Xu, Guanyun Wang, Baixuan Xu. Multiparameter diagnostic model based on 18F-FDG PET metabolic parameters and clinical variables can differentiate nonmetastatic gallbladder cancer and cholecystitis. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-10599-7
|
89 |
Wei-Yu Xu, Hao-Hai Zhang, Xiao-Bo Yang, Yi Bai, Jian-Zhen Lin, Jun-Yu Long, Jian-Ping Xiong, Jun-Wei Zhang, Xin-Ting Sang, Hai-Tao Zhao. Prognostic significance of combined preoperative fibrinogen and CA199 in gallbladder cancer patients. World Journal of Gastroenterology 2018; 24(13): 1451-1463 doi: 10.3748/wjg.v24.i13.1451
|
90 |
Teviah E. Sachs, Oluseyi Akintorin, Jennifer Tseng. How Should Gallbladder Cancer Be Managed?. Advances in Surgery 2018; 52(1): 89 doi: 10.1016/j.yasu.2018.04.003
|
91 |
Pavan Baichan, Previn Naicker, Tanya Nadine Augustine, Martin Smith, Geoffrey Candy, John Devar, Ekene Emmanuel Nweke. Proteomic analysis identifies dysregulated proteins and associated molecular pathways in a cohort of gallbladder cancer patients of African ancestry. Clinical Proteomics 2023; 20(1) doi: 10.1186/s12014-023-09399-9
|
92 |
|
93 |
Jing Zhu, Chenxi Yang, Siyu Song, Ruting Wang, Liqiang Gu, Zhongjian Chen. Classification of multiple cancer types by combination of plasma-based near-infrared spectroscopy analysis and machine learning modeling. Analytical Biochemistry 2023; 669: 115120 doi: 10.1016/j.ab.2023.115120
|
94 |
Baek Gil Kim, Sung Hwan Lee, Yeonsue Jang, Suki Kang, Chang Moo Kang, Nam Hoon Cho. Differentially expressed genes associated with high metabolic tumor volume served as diagnostic markers and potential therapeutic targets for pancreatic cancer. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05181-z
|
95 |
Wenqing Bao, Anan Xu, Shubin Ni, Bo Wang, Humaira Urmi, Bin Zhao, Yongmei You, Hai Hu. Is there a role for growth status in distinguishing gallbladder adenomas from cholesterol polyps? – A retrospective study based on 520 cholecystectomy patients. Scandinavian Journal of Gastroenterology 2021; 56(12): 1450 doi: 10.1080/00365521.2021.1970220
|
96 |
Meraj Ahmed, Hirdaya Hulas Nag, Pankaj Meena. Clinical approach to patients with thick wall gallbladder. Egyptian Journal of Radiology and Nuclear Medicine 2023; 54(1) doi: 10.1186/s43055-023-01137-3
|
97 |
Zeyang Chen, Zining Liu, Yuyang Zhang, Pengyuan Wang, Hongqiao Gao. <p>Combination of CA19-9 and the Neutrophil-to-Lymphocyte Ratio for the Differential Diagnosis of Gallbladder Carcinoma</p>. Cancer Management and Research 2020; : 4475 doi: 10.2147/CMAR.S255480
|
98 |
Yigang Chang, Qiang Li, Qian Wu, Limin Chi, Xiaogang Bi, Qingmin Zeng, Huaying Huo. Impact of surgical strategies on the survival of gallbladder cancer patients: analysis of 715 cases. World Journal of Surgical Oncology 2020; 18(1) doi: 10.1186/s12957-020-01915-7
|
99 |
Saurabh Rai, Chandra Shekhar, Osman Musa, Nisar Ansari, Rahul Agrawal, Rajat Agrawal, Almol Bhore, Shams Alam. Role of Tumour Markers Carbohydrate Antigen 19-9, Carcinoembryonic Antigen, & Alpha Fetoprotein in Carcinoma Gall Bladder. Journal of Evolution of Medical and Dental Sciences 2021; 10(10): 719 doi: 10.14260/jemds/2021/154
|
100 |
Mitsuru Sugimoto, Rei Suzuki, Yoshihiro Nozawa, Tadayuki Takagi, Naoki Konno, Hiroyuki Asama, Yuki Sato, Hiroki Irie, Jun Nakamura, Mika Takasumi, Minami Hashimoto, Tsunetaka Kato, Ryoichiro Kobashi, Osamu Suzuki, Yuko Hashimoto, Takuto Hikichi, Hiromasa Ohira. Clinical usefulness and acceleratory effect of macrophage inhibitory cytokine-1 on biliary tract cancer: an experimental biomarker analysis. Cancer Cell International 2022; 22(1) doi: 10.1186/s12935-022-02668-x
|
101 |
Zanele Nsingwane, Geoffrey Candy, John Devar, Jones Omoshoro-Jones, Martin Smith, Ekene Nweke. Immunotherapeutic strategies in pancreatic ductal adenocarcinoma (PDAC): current perspectives and future prospects. Molecular Biology Reports 2020; 47(8): 6269 doi: 10.1007/s11033-020-05648-4
|
102 |
Tianqi An, Qiu Hui, Hong Zong, Linhua Liu, Xinguang Cao, Rui Li, Shuang Hu, Yiyi Liu, Jia Li, Ruihua Zhao. Efficacy and safety of anlotinib plus anti-PD-1 agents in patients with refractory advanced biliary tract cancers. Clinical and Translational Oncology 2024; 26(8): 2006 doi: 10.1007/s12094-024-03425-4
|